SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-042425
Filing Date
2024-05-13
Accepted
2024-05-13 17:22:58
Documents
10
Effectiveness Date
2024-05-13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205709-s8_akanda.htm S-8 55124
2 OPINION OF GOWLING WLG (CANADA) LLP ea020570901ex5-1_akanda.htm EX-5.1 53662
3 CONSENT OF GREEN GROWTH CPAS, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020570901ex23-1_akanda.htm EX-23.1 2266
4 FILING FEE TABLE ea020570901ex-fee_akanda.htm EX-FILING FEES 20848
5 GRAPHIC image_003.jpg GRAPHIC 3914
6 GRAPHIC image_004.jpg GRAPHIC 3914
7 GRAPHIC image_006.jpg GRAPHIC 3914
8 GRAPHIC image_007.jpg GRAPHIC 3914
9 GRAPHIC image_001.jpg GRAPHIC 3090
10 GRAPHIC image_002.jpg GRAPHIC 7069
  Complete submission text file 0001213900-24-042425.txt   169362
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279381 | Film No.: 24940401
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)